Arca Biopharma reported $1.74M in Selling and Administration Expenses for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Amgen AMGN:US $ 1.33B 99M
Arca Biopharma ABIO:US $ 1.74M 513K
Biogen BIIB:US $ 572.6M 62.3M
Brainstorm Cell Therapeutics BCLI:US $ 2.48M 381K
Bristol Myers Squibb BMY:US $ 1.78B 46M
Capricor Therapeutics CAPR:US 2.36M 359.17K
Cytokinetics CYTK:US $ 42.72M 9.65M
Cytrx CYTR:US 51.91K 1.93M
Daiichi Sankyo 4568:JP 96.37B 8.36B
Gilead Sciences GILD:US $ 1.36B 274M
GlaxoSmithKline GSK:LN 195.5B 18.5B
Laboratory Of America LH:US $ 486M 21.9M
Myriad Genetics MYGN:US $ 127.1M 16.5M
Otsuka Holdings 4578:JP 184.9B 30.4B
Pfizer PFE:US $ 3.2B 506M
United Therapeutics UTHR:US $ 141.5M 62.5M